
First-in-human trial of CRISPR gene-editing therapy safely lowers cholesterol and triglyceride
“This is really unprecedented. A single treatment that simultaneously lowered LDL cholesterol and triglycerides,” said Luke J. Laffin, M.D., lead study author and a preventive cardiologist at the Cleveland Clinic








